Autophagy in Rheumatoid Arthritis: Molecular Mechanisms, Diagnostic Biomarkers, and Emerging Therapeutic Strategies

Rheumatoid arthritis (RA) is a chronic autoimmune disorder marked by persistent synovial inflammation, joint destruction, and systemic complications. Recent research has revealed the complex involvement of autophagy, a cellular degradation and recycling process, in the pathogenesis and progression of RA. This review provides a comprehensive analysis of autophagy's multifaceted roles across immune regulation, synovial hyperplasia, osteoclastogenesis, and antigen presentation. Particular attention is given to the dualistic nature of autophagy, which may exert both protective and pathogenic effects depending on the cellular context and disease stage. We explore key molecular pathways regulating autophagy, including the mTOR, AMPK, and ULK1 axes, and detail how these are modulated by cytokines and signaling molecules characteristic of the RA inflammatory milieu. Epigenetic and genetic factors, including polymorphisms in ATG and BECN1 genes, microRNA regulation, and histone modifications, are also examined for their impact on autophagic flux and immune dysregulation. The diagnostic potential of autophagy-related biomarkers is discussed through transcriptomic and bioinformatics studies that stratify RA subtypes and correlate autophagic activity with disease severity. Additionally, we review therapeutic strategies targeting autophagy, encompassing conventional DMARDs, biologics, small molecules, nanoparticles, and phytochemicals. While modulating autophagy shows clinical promise, challenges remain regarding safety, specificity, and long-term efficacy. The integration of high-throughput omics technologies with artificial intelligence presents new opportunities to refine diagnostic precision and develop personalized therapeutic interventions. This review underscores the necessity of further translational research to define context-specific roles of autophagy in RA and to harness its potential in advancing precision medicine.

Authors

Institutions

Publication Details

Journal
Inflammation
Published
2026-01-09
DOI
https://doi.org/10.1007/s10753-025-02406-1
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autophagy in Rheumatoid Arthritis: Molecular Mechanisms, Diagnostic Biomarkers, and Emerging Therapeutic Strategies

Amir Nasrollahizadeh, Soheil Rahmati, Fatemeh Esmaeilpour Moallem, Ehsan Amini-Salehi et al.
Inflammation
Autophagy in Disease and Therapy
article

Autophagy in Rheumatoid Arthritis: Molecular Mechanisms, Diagnostic Biomarkers, and Emerging Therapeutic Strategies

Amir Nasrollahizadeh, Soheil Rahmati, Fatemeh Esmaeilpour Moallem, Ehsan Amini-Salehi, Mohammad Sadra Gholami Chahkand, Eftekhar Azarm, Mehdi Karimi, Parisa Alsadat Dadkhah, Mohammad Amin Karimi
article en

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disorder marked by persistent synovial inflammation, joint destruction, and systemic complications. Recent research has revealed the complex involvement of autophagy, a cellular degradation and recycling process, in the pathogenesis and progression of RA. This review provides a comprehensive analysis of autophagy's multifaceted roles across immune regulation, synovial hyperplasia, osteoclastogenesis, and antigen presentation. Particular attention is given to the dualistic nature of autophagy, which may exert both protective and pathogenic effects depending on the cellular context and disease stage. We explore key molecular pathways regulating autophagy, including the mTOR, AMPK, and ULK1 axes, and detail how these are modulated by cytokines and signaling molecules characteristic of the RA inflammatory milieu. Epigenetic and genetic factors, including polymorphisms in ATG and BECN1 genes, microRNA regulation, and histone modifications, are also examined for their impact on autophagic flux and immune dysregulation. The diagnostic potential of autophagy-related biomarkers is discussed through transcriptomic and bioinformatics studies that stratify RA subtypes and correlate autophagic activity with disease severity. Additionally, we review therapeutic strategies targeting autophagy, encompassing conventional DMARDs, biologics, small molecules, nanoparticles, and phytochemicals. While modulating autophagy shows clinical promise, challenges remain regarding safety, specificity, and long-term efficacy. The integration of high-throughput omics technologies with artificial intelligence presents new opportunities to refine diagnostic precision and develop personalized therapeutic interventions. This review underscores the necessity of further translational research to define context-specific roles of autophagy in RA and to harness its potential in advancing precision medicine.

InflammationVol. 49(1)
Isfahan University of Medical Sciences (IR), Golestan University (IR), Guilan University of Medical Sciences (IR), Golestan University of Medical Sciences (IR), Shahid Beheshti University of Medical Sciences (IR), Tehran University of Medical Sciences (IR), Bogomolets National Medical University (UA), Mazandaran University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 94%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.